World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Neuroscience 67 2878 2631 276 251 311 16540

Philip N. Patsalos publications per year

The chart shows the history of publications by Philip N. Patsalos between 1963 and 2024, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Philip N. Patsalos published across 62 years, from 1963 to 2024, averaging 6.3 papers a year. Output peaked at 78 publications in 2022. 2 of the 393 publications appeared in the last two years.

No. of publications
25 50 75
Bar chart. Horizontal axis: year, 1963 to 2024. Vertical axis: number of publications, 0 to 78. Peak 78 publications in 2022. 1963: 1 publication 1964: 1 publication 1965: 0 publications 1966: 0 publications 1967: 0 publications 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 0 publications 1972: 0 publications 1973: 0 publications 1974: 1 publication 1975: 0 publications 1976: 0 publications 1977: 3 publications 1978: 0 publications 1979: 0 publications 1980: 4 publications 1981: 1 publication 1982: 4 publications 1983: 1 publication 1984: 1 publication 1985: 4 publications 1986: 2 publications 1987: 2 publications 1988: 4 publications 1989: 1 publication 1990: 7 publications 1991: 4 publications 1992: 5 publications 1993: 11 publications 1994: 8 publications 1995: 7 publications 1996: 10 publications 1997: 9 publications 1998: 3 publications 1999: 11 publications 2000: 8 publications 2001: 8 publications 2002: 11 publications 2003: 12 publications 2004: 12 publications 2005: 17 publications 2006: 9 publications 2007: 5 publications 2008: 6 publications 2009: 7 publications 2010: 42 publications 2011: 6 publications 2012: 16 publications 2013: 14 publications 2014: 2 publications 2015: 3 publications 2016: 10 publications 2017: 2 publications 2018: 6 publications 2019: 4 publications 2020: 7 publications 2021: 1 publication 2022: 78 publications 2023: 1 publication 2024: 1 publication
1963 2024

393 publications in total across all disciplines

View publications per year as a table
Philip N. Patsalos: publications per year, 1963 to 2024
Year Publications
1963 1
1964 1
1965 0
1966 0
1967 0
1968 0
1969 0
1970 0
1971 0
1972 0
1973 0
1974 1
1975 0
1976 0
1977 3
1978 0
1979 0
1980 4
1981 1
1982 4
1983 1
1984 1
1985 4
1986 2
1987 2
1988 4
1989 1
1990 7
1991 4
1992 5
1993 11
1994 8
1995 7
1996 10
1997 9
1998 3
1999 11
2000 8
2001 8
2002 11
2003 12
2004 12
2005 17
2006 9
2007 5
2008 6
2009 7
2010 42
2011 6
2012 16
2013 14
2014 2
2015 3
2016 10
2017 2
2018 6
2019 4
2020 7
2021 1
2022 78
2023 1
2024 1
Total 393
Download as CSV

Philip N. Patsalos publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Philip N. Patsalos sits on this spectrum.

No. of scientists
100 200 300 400 500
Bar chart with 86 bars. Horizontal axis: publications, 38–47 to 887+. Vertical axis: number of scientists, 0 to 539. Most scientists, 539, have 98–107 publications. The last bar groups every scientist with 887 publications or more. The highlighted bar, 308–317 publications, is where this scientist sits. 38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientist 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38–47 publications 887+

This scientist: 311 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

View publications distribution as a table
Number of Neuroscience scientists by publication count, Research.com 2026 ranking edition. Based on 9,597 ranked scientists.
Publications Scientists This scientist
38–47 18
48–57 79
58–67 193
68–77 323
78–87 406
88–97 452
98–107 539
108–117 505
118–127 522
128–137 469
138–147 456
148–157 459
158–167 397
168–177 383
178–187 350
188–197 302
198–207 306
208–217 262
218–227 242
228–237 220
238–247 203
248–257 174
258–267 176
268–277 175
278–287 125
288–297 116
298–307 127
308–317 128 311
318–327 99
328–337 89
338–347 78
348–357 96
358–367 66
368–377 59
378–387 65
388–397 54
398–407 48
408–417 49
418–427 34
428–437 31
438–447 30
448–457 31
458–467 36
468–477 40
478–487 35
488–497 30
498–507 23
508–517 26
518–527 20
528–537 23
538–547 20
548–557 20
558–567 17
568–577 14
578–587 20
588–597 20
598–607 19
608–617 18
618–627 17
628–637 11
638–647 11
648–657 11
658–667 8
668–677 7
678–687 11
688–697 10
698–707 4
708–717 6
718–727 5
728–737 5
738–747 9
748–757 9
758–767 3
768–777 7
778–787 7
788–797 6
798–807 2
808–817 2
818–827 7
828–837 0
838–847 9
848–857 3
858–867 1
868–877 3
878–886 6
887+ 100
Download as CSV

Philip N. Patsalos D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Philip N. Patsalos sits on this spectrum.

No. of scientists
100 200 300 400 500
Bar chart with 68 bars. Horizontal axis: D-Index, 30–31 to 163+. Vertical axis: number of scientists, 0 to 512. Most scientists, 512, have 46–47 D-Index. The last bar groups every scientist with 163 D-Index or more. The highlighted bar, 66–67 D-Index, is where this scientist sits. 30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30–31 D-Index 163+

This scientist: 67 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

View D-Index distribution as a table
Number of Neuroscience scientists by D-index, Research.com 2026 ranking edition. Based on 9,597 ranked scientists.
D-Index Scientists This scientist
30–31 42
32–33 172
34–35 296
36–37 435
38–39 459
40–41 456
42–43 467
44–45 478
46–47 512
48–49 435
50–51 425
52–53 418
54–55 392
56–57 357
58–59 334
60–61 328
62–63 260
64–65 278
66–67 239 67
68–69 250
70–71 210
72–73 200
74–75 189
76–77 170
78–79 146
80–81 113
82–83 126
84–85 100
86–87 84
88–89 99
90–91 84
92–93 85
94–95 72
96–97 76
98–99 45
100–101 49
102–103 43
104–105 32
106–107 45
108–109 50
110–111 32
112–113 39
114–115 32
116–117 29
118–119 27
120–121 19
122–123 23
124–125 27
126–127 16
128–129 24
130–131 13
132–133 21
134–135 17
136–137 14
138–139 15
140–141 10
142–143 10
144–145 13
146–147 9
148–149 8
150–151 6
152–153 6
154–155 7
156–157 7
158–159 10
160–161 4
162 8
163+ 100
Download as CSV

Overview

Philip N. Patsalos is affiliated with University College London in the United Kingdom. Their research primarily focuses on the field of Medicine, with specific work in Psychiatry and Mental Health, Pediatrics, Perinatology and Child Health, Pharmacology, Infectious Diseases, and Oncology.

The scientist has contributed to various topics including epilepsy research and treatment, pharmacological effects and toxicity studies, drug transport and resistance mechanisms, cannabis and cannabinoid research, COVID-19 clinical research studies, antibiotics pharmacokinetics and efficacy, and SARS-CoV-2 and COVID-19 research.

Recent publications by Philip N. Patsalos include:

  • "Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs," 2020, Epilepsia
  • "Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects," 2020, Expert Opinion on Drug Metabolism & Toxicology
  • "Pharmacokinetic characterization of favipiravir in patients with COVID-19," 2022, British Journal of Clinical Pharmacology
  • "Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force," 2022, Epilepsia Open
  • "Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study," 2020, BMC Neurology

Frequent co-authors of Philip N. Patsalos include:

  • Cecilie Johannessen Landmark
  • Svein I. Johannessen
  • Jerzy P. Szaflarski
  • Barry E. Gidal
  • Kevan VanLandingham

The scientist's work is regularly published in several specialized venues, with multiple publications in Expert Opinion on Drug Metabolism & Toxicology, as well as contributions to Epilepsia, British Journal of Clinical Pharmacology, Epilepsia Open, and BMC Neurology.

Best Publications

  • Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

    Philip N. Patsalos;David J. Berry;Blaise F. D. Bourgeois;James C. Cloyd

  • Pharmacokinetic profile of levetiracetam: toward ideal characteristics.

    P.N. Patsalos

  • Clinical pharmacokinetics of levetiracetam

    Philip N. Patsalos

  • The Importance of Drug Interactions in Epilepsy Therapy

    Philip N. Patsalos;Walter Fröscher;Francesco Pisani;Clementina M. Van Rijn

  • Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

    Philip N Patsalos;Emilio Perucca

  • Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

    Philip N Patsalos;Emilio Perucca

  • Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

    C.L.P. Deckers;S.J. Czuczwar;Y.A. Hekster;A.J.M. Keyser

  • Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update.

    Philip N Patsalos;Edgar P Spencer;Dave J Berry

  • Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study

    R Katzenschlager;A Evans;A Manson;P N Patsalos

  • Therapeutic drug monitoring of the newer antiepileptic drugs.

    Svein I. Johannessen;Dina Battino;David J. Berry;Meir Bialer

  • Drug interactions involving the new second- and third-generation antiepileptic drugs.

    Cecilie Johannessen Landmark;Philip N. Patsalos

  • The new generation of GABA enhancers. Potential in the treatment of epilepsy.

    Stanislaw J. Czuczwar;Philip N. Patsalos

  • Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State Principle:

    N. A. Lassen;P. A. Bartenstein;A. A. Lammertsma;M. C. Prevett

  • The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist.

    Philip N. Patsalos

  • Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs

    Philip N. Patsalos;Philip N. Patsalos

  • The excitatory amino acid antagonist d-CPP-ene (SDZ EAA-494) in patients with epilepsy

    S. Sveinbjornsdottir;J.W.A.S. Sander;D. Upton;P.J. Thompson

  • Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial.

    Alan W.C. Yuen;Josemir W. Sander;Dominique Fluegel;Philip N. Patsalos

  • Therapeutic drug monitoring of antiepileptic drugs by use of saliva.

    Philip N. Patsalos;Dave J. Berry

  • Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia

    Joanna M Zakrzewska;Philip N Patsalos

  • INVESTIGATION INTO THE ROLE OF N-ACETYLASPARTATE IN CEREBRAL OSMOREGULATION

    Deanna L. Taylor;Siân E. C. Davies;Tihomir P. Obrenovitch;Mary H. Doheny

  • A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED ADD-ON TRIAL OF LAMOTRIGINE IN PATIENTS WITH SEVERE EPILEPSY

    J.W.A.S. Sander;P.N. Patsalos;J.R. Oxley;M.J. Hamilton

  • Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia.

    J M Zakrzewska;P N Patsalos

  • Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11 -epoxide

    T. Warner;P.N. Patsalos;M. Prevett;A.A. Elyas

  • Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.

    Philip N. Patsalos

  • Clinical pharmacokinetics of new antiepileptic drugs.

    M.C. Walker;P.N. Patsalos

Frequent Co-Authors

Blaise F. D. Bourgeois
Blaise F. D. Bourgeois Boston Children's Hospital
Josemir W. Sander
Josemir W. Sander University College London
Simon Shorvon
Simon Shorvon University College London
John S. Duncan
John S. Duncan University College London
Matthew C. Walker
Matthew C. Walker University College London
Gail S. Bell
Gail S. Bell University College London
Graeme J. Sills
Graeme J. Sills University of Glasgow
John G. R. Jefferys
John G. R. Jefferys University of Oxford
Emilio Perucca
Emilio Perucca University of Pavia
Svein I. Johannessen
Svein I. Johannessen Oslo University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Neuroscience, several related online degree programs and professional pathways are worth considering. Many students pursue advanced studies in fields like social work, psychology, and behavioral analysis, which offer unique insights into the human mind and behavior.

For those focused on affordability, the most affordable online msw programs provide a path into mental health care and social services. These programs combine flexible study options with practical experience, opening doors for roles such as clinical social workers or case managers.

If you are interested in behavior analysis, there are bcba programs available online that train professionals to work with individuals experiencing behavioral challenges, including those on the autism spectrum.

Students seeking faster degree completion options will find value in online social work programs and accelerated psychology bachelor's degree programs. These allow you to pursue your interests in psychology or social work at a quicker pace.

Exploring these related degrees can broaden your career prospects, whether you wish to work in clinical practice, research, or community-based roles within the field of Neuroscience.

Best Scientists Citing Philip N. Patsalos

Trending Scientists

Recently Published Articles